{
    "Trade/Device Name(s)": [
        "VITROS Chemistry Products hsCRP Reagent"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K160712",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103557"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DCK"
    ],
    "Summary Letter Date": "June 9, 2017",
    "Summary Letter Received Date": "June 12, 2017",
    "Submission Date": "July 13, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.5270"
    ],
    "Regulation Name(s)": [
        "C-reactive protein immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "C-reactive protein (CRP)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITROS 5,1 FS Chemistry System",
        "VITROS 4600 Chemistry System",
        "VITROS 5600 Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Two-point immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Immunoturbidimetric assay"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS Chemistry Products hsCRP Reagent for quantitative measurement of C-reactive protein using immunoturbidimetric assay on VITROS chemistry systems.",
    "Indications for Use Summary": "For in vitro quantitative measurement of C-reactive protein in human serum and plasma to evaluate conditions associated with inflammation in otherwise healthy individuals.",
    "fda_folder": "Immunology"
}